References

Anti-Psoriasis Drug Screening. Accessed 24/05/2019 [Online]. Available:https://www.mattek.com/application/anti-psoriasis-drug-screening/[Accessed].
MelanoDerm®. Accessed 9th August 2019.
Melanoma®. Accessed 9th august 2019 [Online]. Available:https://www.mattek.com/products/melanoma/[Accessed].
Psoriasis Like” model from ATERA Labs. Accessed 9th August 2019[Online]. Available:http://www.ateralabs.com;http://www.ateralabs.com/downloads/ATERA-PRODUCTS-web.pdf[Accessed].
Psoriasis®. Accessed 9th August 2019. [Online]. Available:https://www.mattek.com/products/psoriasis/[Accessed].
Routes for drug administration trought the skin. Assessed 17/05/2019 [Online]. Available:https://www.msdmanuals.com/home/drugs/administration-and-kinetics-of-drugs/drug-administration[Accessed].
ABACI, H., GUO, Z., DOUCET, Y., JACKÓW, J. & CHRISTIANO, A. 2017. Next generation human skin constructs as advanced tools for drug development.Experimental Biology and Medicine, 242, 1657-1668.
ABD, E., YOUSEF, S. A., PASTORE, M. N., TELAPROLU, K., MOHAMMED, Y. H., et al. 2016. Skin models for the testing of transdermal drugs. Clin Pharmacol, 8, 163-176.
ABRAHAM, W. & DOWNING, D. T. 1989. Preparation of model membranes for skin permeability studies using stratum corneum lipids. J Invest Dermatol, 93, 809-13.
AGACHE, P. 2004. Metrology of the stratum corneum. Measuring the skin: non-invasive investigations, physiology, normal constants.Springer, Berlin.
ALÉPÉE, N., GRANDIDIER, M.-H., TORNIER, C. & COTOVIO, J. 2015. An integrated testing strategy for in vitro skin corrosion and irritation assessment using SkinEthic™ Reconstructed Human Epidermis.Toxicology in Vitro, 29, 1779-1792.
ALÉPÉE, N., GRANDIDIER, M. H. & COTOVIO, J. 2014. Sub-categorisation of skin corrosive chemicals by the EpiSkin™ reconstructed human epidermis skin corrosion test method according to UN GHS: Revision of OECD Test Guideline 431. Toxicology in Vitro, 28, 131-145.
ALKILANI, A. Z., MCCRUDDEN, M. T. & DONNELLY, R. F. 2015. Transdermal Drug Delivery: Innovative Pharmaceutical Developments Based on Disruption of the Barrier Properties of the stratum corneum.Pharmaceutics, 7, 438-70.
ALVAREZ-FIGUEROA, M. J., PESSOA-MAHANA, C. D., PALAVECINO-GONZÁLEZ, M. E., MELLA-RAIPÁN, J., ESPINOSA-BUSTOS, C., et al. 2011. Evaluation of the Membrane Permeability (PAMPA and Skin) of Benzimidazoles with Potential Cannabinoid Activity and their Relation with the Biopharmaceutics Classification System (BCS). AAPS PharmSciTech, 12, 573-578.
AMELIAN, A., WASILEWSKA, K., MEGIAS, D. & WINNICKA, K. 2017. Application of standard cell cultures and 3D in vitro tissue models as an effective tool in drug design and development. Pharmacological Reports, 69, 861-870.
AU - BENNY, P., AU - BADOWSKI, C., AU - LANE, E. B. & AU - RAGHUNATH, M. 2016. Improving 2D and 3D Skin In Vitro Models Using Macromolecular Crowding. JoVE , e53642.
BALÁZS, B., VIZSERÁLEK, G., BERKÓ, S., BUDAI-SZŰCS, M., KELEMEN, A., et al. 2016. Investigation of the Efficacy of Transdermal Penetration Enhancers Through the Use of Human Skin and a Skin Mimic Artificial Membrane. Journal of Pharmaceutical Sciences,105, 1134-1140.
BARBER, E. D., TEETSEL, N. M., KOLBERG, K. F. & GUEST, D. 1992. A comparative study of the rates of in vitro percutaneous absorption of eight chemicals using rat and human skin. Fundamental and Applied Toxicology, 19, 493-497.
BERBEN, P., BAUER-BRANDL, A., BRANDL, M., FALLER, B., FLATEN, G. E., et al. 2018. Drug permeability profiling using cell-free permeation tools: Overview and applications. European Journal of Pharmaceutical Sciences, 119, 219-233.
BOCHEŃSKA, K., SMOLIŃSKA, E., MOSKOT, M., JAKÓBKIEWICZ-BANECKA, J. & GABIG-CIMIŃSKA, M. 2017. Models in the Research Process of Psoriasis.International Journal of Molecular Sciences, 18, 2514.
BOND, J. R. & BARRY, B. W. 1988. Hairless Mouse Skin is Limited as a Model for Assessing the Effects of Penetration Enhancers in Human Skin.Journal of Investigative Dermatology, 90, 810-813.
BONFERONI, M. C., RIVA, F., INVERNIZZI, A., DELLERA, E., SANDRI, G., et al. 2018. Alpha tocopherol loaded chitosan oleate nanoemulsions for wound healing. Evaluation on cell lines and ex vivo human biopsies, and stabilization in spray dried Trojan microparticles.European Journal of Pharmaceutics and Biopharmaceutics,123, 31-41.
BOS, J. D. & MEINARDI, M. M. 2000. The 500 Dalton rule for the skin penetration of chemical compounds and drugs. Exp Dermatol,9, 165-9.
BRAGAGNI, M., MENNINI, N., MAESTRELLI, F., CIRRI, M. & MURA, P. 2012. Comparative study of liposomes, transfersomes and ethosomes as carriers for improving topical delivery of celecoxib. Drug Delivery,19, 354-361.
BURNS, E. M., TOBER, K. L., RIGGENBACH, J. A., SCHICK, J. S., LAMPING, K. N., et al. 2013. Preventative topical diclofenac treatment differentially decreases tumor burden in male and female Skh-1 mice in a model of UVB-induced cutaneous squamous cell carcinoma.Carcinogenesis, 34, 370-377.
CAL, K. 2006. How does the type of vehicle influence the in vitro skin absorption and elimination kinetics of terpenes? Archives of Dermatological Research, 297, 311-315.
CAMBIER, L., WEATHERSPOON, A., DEFAWEUX, V., BAGUT, E. T., HEINEN, M. P., et al. 2014. Assessment of the cutaneous immune response during Arthroderma benhamiae and A. vanbreuseghemii infection using an experimental mouse model. Br J Dermatol, 170, 625-33.
CANTON, I., COLE, D. M., KEMP, E. H., WATSON, P. F., CHUNTHAPONG, J., et al. 2010. Development of a 3D human in vitro skin co-culture model for detecting irritants in real-time. Biotechnol Bioeng, 106, 794-803.
CHEN, Y., WU, Q., ZHANG, Z., YUAN, L., LIU, X., et al. 2012. Preparation of curcumin-loaded liposomes and evaluation of their skin permeation and pharmacodynamics. Molecules, 17, 5972-87.
CHIRICOZZI, A., NOGRALES, K. E., JOHNSON-HUANG, L. M., FUENTES-DUCULAN, J., CARDINALE, I., et al. 2014. IL-17 induces an expanded range of downstream genes in reconstituted human epidermis model. PLoS One, 9, e90284.
CHOWHAN, Z. T. & PRITCHARD, R. 1978. Effect of Surfactants on Percutaneous Absorption of Naproxen I: Comparisons of Rabbit, Rat, and Human Excised Skin. Journal of Pharmaceutical Sciences,67, 1272-1274.
CILURZO, F., MINGHETTI, P. & SINICO, C. 2007. Newborn pig skin as model membrane in in vitro drug permeation studies: A technical note.AAPS PharmSciTech, 8, 97-100.
CLARES, B., CALPENA, A. C., PARRA, A., ABREGO, G., ALVARADO, H., et al. 2014. Nanoemulsions (NEs), liposomes (LPs) and solid lipid nanoparticles (SLNs) for retinyl palmitate: effect on skin permeation.Int J Pharm, 473, 591-8.
COMMANDEUR, S., VAN DRONGELEN, V., DE GRUIJL, F. R. & EL GHALBZOURI, A. 2012. Epidermal growth factor receptor activation and inhibition in 3D in vitro models of normal skin and human cutaneous squamous cell carcinoma. Cancer Sci, 103, 2120-6.
CORICOVAC, D., DEHELEAN, C., MOACA, E.-A., PINZARU, I., BRATU, T., et al. 2018. Cutaneous Melanoma—A Long Road from Experimental Models to Clinical Outcome: A Review. International Journal of Molecular Sciences, 19, 1566.
COZZI, S.-J., LE, T. T., OGBOURNE, S. M., JAMES, C. & SUHRBIER, A. 2013. Effective treatment of squamous cell carcinomas with ingenol mebutate gel in immunologically intact SKH1 mice. Archives of dermatological research, 305, 79-83.
CROSS, S. E., MAGNUSSON, B. M., WINCKLE, G., ANISSIMOV, Y. & ROBERTS, M. S. 2003. Determination of the effect of lipophilicity on the in vitro permeability and tissue reservoir characteristics of topically applied solutes in human skin layers. J Invest Dermatol, 120,759-64.
DAI, N.-T., CHANG, H.-I., WANG, Y.-W., FU, K.-Y., HUANG, T.-C., et al. 2018a. Restoration of skin pigmentation after deep partial or full-thickness burn injury. Advanced Drug Delivery Reviews,123, 155-164.
DAI, N. T., HUANG, W. S., CHANG, F. W., WEI, L. G., HUANG, T. C., et al. 2018b. Development of a Novel Pre-Vascularized Three-Dimensional Skin Substitute Using Blood Plasma Gel. Cell Transplant,27, 1535-1547.
DAS, B., SEN, S. O., MAJI, R., NAYAK, A. K. & SEN, K. K. 2017. Transferosomal gel for transdermal delivery of risperidone: Formulation optimization and ex vivo permeation. Journal of Drug Delivery Science and Technology, 38, 59-71.
DESMET, E., RAMADHAS, A., LAMBERT, J. & VAN GELE, M. 2017. In vitro psoriasis models with focus on reconstructed skin models as promising tools in psoriasis research. Experimental biology and medicine (Maywood, N.J.), 242, 1158-1169.
DIAS, M., HADGRAFT, J. & LANE, M. E. 2007. Influence of membrane–solvent–solute interactions on solute permeation in model membranes. International Journal of Pharmaceutics, 336,108-114.
DOBRIČIĆ, V., MARKOVIĆ, B., NIKOLIC, K., SAVIĆ, V., VLADIMIROV, S., et al. 2014. 17β-carboxamide steroids – in vitro prediction of human skin permeability and retention using PAMPA technique.European Journal of Pharmaceutical Sciences, 52, 95-108.
DRAGICEVIC-CURIC, N., GRÄFE, S., GITTER, B., WINTER, S. & FAHR, A. 2010. Surface charged temoporfin-loaded flexible vesicles: In vitro skin penetration studies and stability. International Journal of Pharmaceutics, 384, 100-108.
DRAGICEVIC-CURIC, N., SCHEGLMANN, D., ALBRECHT, V. & FAHR, A. 2008. Temoporfin-loaded invasomes: Development, characterization and in vitro skin penetration studies. Journal of Controlled Release,127, 59-69.
DUBEY, V., MISHRA, D., DUTTA, T., NAHAR, M., SARAF, D. K., et al.2007. Dermal and transdermal delivery of an anti-psoriatic agent via ethanolic liposomes. J Control Release, 123, 148-54.
EGAWA, M., NOMURA, J. & IWAKI, H. 2010. The evaluation of the amount of cis- and trans-urocanic acid in the stratum corneum by Raman spectroscopy. Photochem Photobiol Sci, 9, 730-3.
ELIAS, P. M., ARBISER, J., BROWN, B. E., ROSSITER, H., MAN, M.-Q., et al. 2008. Epidermal vascular endothelial growth factor production is required for permeability barrier homeostasis, dermal angiogenesis, and the development of epidermal hyperplasia: implications for the pathogenesis of psoriasis. The American journal of pathology,173, 689-699.
ELMOSLEMANY, R. M., ABDALLAH, O. Y., EL-KHORDAGUI, L. K. & KHALAFALLAH, N. M. 2012. Propylene Glycol Liposomes as a Topical Delivery System for Miconazole Nitrate: Comparison with Conventional Liposomes. AAPS PharmSciTech, 13, 723-731.
ENGELHART, K., EL HINDI, T., BIESALSKI, H. K. & PFITZNER, I. 2005. In vitro reproduction of clinical hallmarks of eczematous dermatitis in organotypic skin models. Arch Dermatol Res, 297, 1-9.
ENGESLAND, A., SKALKO-BASNET, N. & FLATEN, G. E. 2015. Phospholipid vesicle-based permeation assay and EpiSkin(R) in assessment of drug therapies destined for skin administration. J Pharm Sci,104, 1119-27.
ENGESLAND, A., ŠKALKO-BASNET, N. & FLATEN, G. E. 2016. In vitro models to estimate drug penetration through the compromised stratum corneum barrier. Drug Development and Industrial Pharmacy, 42,1742-1751.
ENGESLAND, A., SKAR, M., HANSEN, T., SKALKO-BASNET, N. & FLATEN, G. E. 2013. New applications of phospholipid vesicle-based permeation assay: permeation model mimicking skin barrier. J Pharm Sci,102, 1588-600.
FALLER, B. 2008. Artificial membrane assays to assess permeability.Curr Drug Metab, 9, 886-92.
FAWAY, É., LAMBERT DE ROUVROIT, C. & POUMAY, Y. 2018. In vitro models of dermatophyte infection to investigate epidermal barrier alterations.Experimental Dermatology, 27, 915-922.
FENTEM, J. H. 1999. Validation of in vitro Tests for Skin Corrosivity.Altex, 16, 150-153.
FENTEM, J. H. & BOTHAM, P. A. 2004. Update on the validation and regulatory acceptance of alternative tests for skin corrosion and irritation. Atla-Alternatives to Laboratory Animals, 32,683-688.
FILOCAMO, G., BRUNETTI, M., COLACECI, F., SASSO, R., TANORI, M., et al. 2016. MK-4101, a Potent Inhibitor of the Hedgehog Pathway, Is Highly Active against Medulloblastoma and Basal Cell Carcinoma.Mol Cancer Ther, 15, 1177-89.
FLATEN, G. E., BUNJES, H., LUTHMAN, K. & BRANDL, M. 2006a. Drug permeability across a phospholipid vesicle-based barrier 2. Characterization of barrier structure, storage stability and stability towards pH changes. Eur J Pharm Sci, 28, 336-43.
FLATEN, G. E., DHANIKULA, A. B., LUTHMAN, K. & BRANDL, M. 2006b. Drug permeability across a phospholipid vesicle based barrier: a novel approach for studying passive diffusion. Eur J Pharm Sci,27, 80-90.
FLATEN, G. E., PALAC, Z., ENGESLAND, A., FILIPOVIC-GRCIC, J., VANIC, Z., et al. 2015. In vitro skin models as a tool in optimization of drug formulation. Eur J Pharm Sci, 75, 10-24.
FORSTER, M., BOLZINGER, M. A., FESSI, H. & BRIANCON, S. 2009. Topical delivery of cosmetics and drugs. Molecular aspects of percutaneous absorption and delivery. Eur J Dermatol, 19, 309-23.
FOWLER, J. 2012. Understanding the Role of Natural Moisturizing Factor in Skin Hydration. Practical dermatology .
FREDERIKSEN, M., STAPLETON, H. M., VORKAMP, K., WEBSTER, T. F., JENSEN, N. M., et al. 2018. Dermal uptake and percutaneous penetration of organophosphate esters in a human skin ex vivo model.Chemosphere, 197, 185-192.
GAUR, P. K., MISHRA, S. & PUROHIT, S. 2013. Solid Lipid Nanoparticles of Guggul Lipid as Drug Carrier for Transdermal Drug Delivery.BioMed Research International, 2013, 10.
GILLET, A., LECOMTE, F., HUBERT, P., DUCAT, E., EVRARD, B., et al. 2011. Skin penetration behaviour of liposomes as a function of their composition. European Journal of Pharmaceutics and Biopharmaceutics, 79, 43-53.
GOMES, M. J., MARTINS, S., FERREIRA, D., SEGUNDO, M. A. & REIS, S. 2014. Lipid nanoparticles for topical and transdermal application for alopecia treatment: development, physicochemical characterization, and in vitro release and penetration studies. Int J Nanomedicine,9, 1231-42.
GREEN, C. B., CHENG, G., CHANDRA, J., MUKHERJEE, P., GHANNOUM, M. A., et al. 2004. RT-PCR detection of Candida albicans ALS gene expression in the reconstituted human epithelium (RHE) model of oral candidiasis and in model biofilms. Microbiology, 150,267-275.
GROEN, D., GOORIS, G. S., PONEC, M. & BOUWSTRA, J. A. 2008. Two new methods for preparing a unique stratum corneum substitute. Biochim Biophys Acta, 1778, 2421-9.
GROVES, R. W., MIZUTANI, H., KIEFFER, J. D. & KUPPER, T. S. 1995. Inflammatory skin disease in transgenic mice that express high levels of interleukin 1 alpha in basal epidermis. Proceedings of the National Academy of Sciences, 92, 11874-11878.
HAQ, A., GOODYEAR, B., AMEEN, D., JOSHI, V. & MICHNIAK-KOHN, B. 2018. Strat-M® synthetic membrane: Permeability comparison to human cadaver skin. International Journal of Pharmaceutics, 547,432-437.
HATHOUT, R. M., WOODMAN, T. J., MANSOUR, S., MORTADA, N. D., GENEIDI, A. S., et al. 2010. Microemulsion formulations for the transdermal delivery of testosterone. European Journal of Pharmaceutical Sciences, 40, 188-196.
HUET, F., SEVERINO-FREIRE, M., CHÉRET, J., GOUIN, O., PRANEUF, J., et al. 2018. Reconstructed human epidermis for in vitro studies on atopic dermatitis: A review. Journal of Dermatological Science,89, 213-218.
HUGHES, M. F. & EDWARDS, B. C. 2010. In vitro dermal absorption of pyrethroid pesticides in human and rat skin. Toxicol Appl Pharmacol, 246, 29-37.
ITOH, T., XIA, J., MAGAVI, R., NISHIHATA, T. & RYTTING, J. H. 1990. Use of shed snake skin as a model membrane for in vitro percutaneous penetration studies: comparison with human skin. Pharm Res,7, 1042-7.
JUNYAPRASERT, V. B., SINGHSA, P., SUKSIRIWORAPONG, J. & CHANTASART, D. 2012. Physicochemical properties and skin permeation of Span 60/Tween 60 niosomes of ellagic acid. International Journal of Pharmaceutics,423, 303-311.
JUREK, I., GÓRAL, I., MIERZYŃSKA, Z., MONIUSZKO-SZAJWAJ, B. & WOJCIECHOWSKI, K. 2019. Effect of synthetic surfactants and soapwort (Saponaria officinalis L.) extract on skin-mimetic model lipid monolayers. Biochimica et Biophysica Acta (BBA) - Biomembranes,1861, 556-564.
KANDAROVA, H., LIEBSCH, M., GENSCHOW, E., GERNER, I., TRAUE, D., et al. 2004. Optimisation of the EpiDerm test protocol for the upcoming ECVAM validation study on in vitro skin irritation tests.Altex-Alternativen Zu Tierexperimenten, 21, 107-114.
KANDAROVA, H., LIEBSCH, M., GERNER, I., SCHMIDT, E., GENSCHOW, E., et al. 2005. The EpiDerm test protocol for the upcoming ECVAM validation study on in vitro skin irritation tests–an assessment of the performance of the optimised test. Altern Lab Anim,33, 351-67.
KANDAROVA, H., LIEBSCH, M., SCHMIDT, E., GENSCHOW, E., TRAUE, D., et al. 2006. Assessment of the skin irritation potential of chemicals by using the SkinEthic reconstructed human epidermal model and the common skin irritation protocol evaluated in the ECVAM skin irritation validation study. Altern Lab Anim, 34, 393-406.
KANSY, M., SENNER, F. & GUBERNATOR, K. 1998. Physicochemical High Throughput Screening:  Parallel Artificial Membrane Permeation Assay in the Description of Passive Absorption Processes. Journal of Medicinal Chemistry, 41, 1007-1010.
KARADZOVSKA, D., BROOKS, J. D., MONTEIRO-RIVIERE, N. A. & RIVIERE, J. E. 2013. Predicting skin permeability from complex vehicles.Advanced Drug Delivery Reviews, 65, 265-277.
KARADZOVSKA, D. & RIVIERE, J. E. 2013. Assessing vehicle effects on skin absorption using artificial membrane assays. European Journal of Pharmaceutical Sciences, 50, 569-576.
KLAR, A. S., ZIMOCH, J. & BIEDERMANN, T. 2017. Skin Tissue Engineering: Application of Adipose-Derived Stem Cells. Biomed Res Int,2017, 9747010.
KLIGMAN, A. M. & CHRISTOPHERS, E. 1963. Preparation of isolated sheets of human stratum corneum. Arch Dermatol, 88, 702-5.
KNUDSEN, N. Ø., RØNHOLT, S., SALTE, R. D., JORGENSEN, L., THORMANN, T., et al. 2012. Calcipotriol delivery into the skin with PEGylated liposomes. European Journal of Pharmaceutics and Biopharmaceutics, 81, 532-539.
KOCH, L., DEIWICK, A., SCHLIE, S., MICHAEL, S., GRUENE, M., et al. 2012. Skin tissue generation by laser cell printing.Biotechnol Bioeng, 109, 1855-63.
KÖLLMER, M., MOSSAHEBI, P., SACHAROW, E., GORISSEN, S., GRÄFE, N., et al. 2019. Investigation of the Compatibility of the Skin PAMPA Model with Topical Formulation and Acceptor Media Additives Using Different Assay Setups. AAPS PharmSciTech, 20, 89.
KUCHLER, S., HENKES, D., ECKL, K. M., ACKERMANN, K., PLENDL, J., et al. 2011. Hallmarks of atopic skin mimicked in vitro by means of a skin disease model based on FLG knock-down. Altern Lab Anim,39, 471-80.
KUCHLER, S., STRUVER, K. & FRIESS, W. 2013. Reconstructed skin models as emerging tools for drug absorption studies. Expert Opin Drug Metab Toxicol, 9, 1255-63.
KUMPUGDEE-VOLLRATH, M., SUBONGKOT, T. & NGAWHIRUNPAT, T. 2013. Model Membrane from Shed Snake Skins. International Journal of Pharmacological and Pharmaceutical Sciences, 7, 669-676.
KUNDU-RAYCHAUDHURI, S., CHEN, Y. J., WULFF, H. & RAYCHAUDHURI, S. P. 2014. Kv1.3 in psoriatic disease: PAP-1, a small molecule inhibitor of Kv1.3 is effective in the SCID mouse psoriasis–xenograft model.J Autoimmun, 55, 63-72.
LANE, P. W. 1972. Two New Mutations in Linkage Group XVI of the House Mouse: Flaky tail and varitint-waddler-J. Journal of Heredity,63, 135-140.
LEE, S. H., JEONG, S. K. & AHN, S. K. 2006. An update of the defensive barrier function of skin. Yonsei Med J, 47, 293-306.
LEE, V., SINGH, G., TRASATTI, J. P., BJORNSSON, C., XU, X., et al. 2014. Design and fabrication of human skin by three-dimensional bioprinting. Tissue Eng Part C Methods, 20, 473-84.
LI, L., FUKUNAGA-KALABIS, M. & HERLYN, M. 2011. The three-dimensional human skin reconstruct model: a tool to study normal skin and melanoma progression. J Vis Exp .
LOFTSSON, T., KONRÁDSDÓTTIR, F. & MÁSSON, M. 2006. Development and evaluation of an artificial membrane for determination of drug availability. International Journal of Pharmaceutics,326, 60-68.
LÖWA, A., JEVTIĆ, M., GORREJA, F. & HEDTRICH, S. 2018. Alternatives to animal testing in basic and preclinical research of atopic dermatitis.Experimental Dermatology, 27, 476-483.
LUO, L., PATEL, A., SINKO, B., BELL, M., WIBAWA, J., et al. 2016. A comparative study of the in vitro permeation of ibuprofen in mammalian skin, the PAMPA model and silicone membrane. International Journal of Pharmaceutics, 505, 14-19.
MA, M., DI, H.-J., ZHANG, H., YAO, J.-H., DONG, J., et al. 2017. Development of phospholipid vesicle-based permeation assay models capable of evaluating percutaneous penetration enhancing effect.Drug Development and Industrial Pharmacy, 43, 2055-2063.
MA, Y., KURTYKA, C. A., BOYAPALLE, S., SUNG, S.-S., LAWRENCE, H., et al. 2008. A small-molecule E2F inhibitor blocks growth in a melanoma culture model. Cancer research, 68, 6292-6299.
MADISON, K. C. 2003. Barrier Function of the Skin: “La Raison d’Être” of the Epidermis. Journal of Investigative Dermatology,121, 231-241.
MANCA, M. L., MANCONI, M., NACHER, A., CARBONE, C., VALENTI, D., et al. 2014. Development of novel diolein–niosomes for cutaneous delivery of tretinoin: Influence of formulation and in vitro assessment.International Journal of Pharmaceutics, 477, 176-186.
MARCONI, A., QUADRI, M., SALTARI, A. & PINCELLI, C. 2018. Progress in melanoma modelling in vitro. Exp Dermatol, 27, 578-586.
MAREPALLY, S., BOAKYE, C. H. A., SHAH, P. P., ETUKALA, J. R., VEMURI, A., et al. 2013. Design, Synthesis of Novel Lipids as Chemical Permeation Enhancers and Development of Nanoparticle System for Transdermal Drug Delivery. PLOS ONE, 8, e82581.
MARIMUTHU, M., BENNET, D. & KIM, S. 2012. Self-assembled nanoparticles of PLGA-conjugated glucosamine as a sustained transdermal drug delivery vehicle. Polymer Journal, 45, 202.
MARKOVIC, B. D., VLADIMIROV, S. M., CUDINA, O. A., ODOVIC, J. V. & KARLJIKOVIC-RAJIC, K. D. 2012. A PAMPA Assay as Fast Predictive Model of Passive Human Skin Permeability of New Synthesized Corticosteroid C-21 Esters. Molecules, 17, 480-491.
MATSUDA, H., WATANABE, N., GEBA, G. P., SPERL, J., TSUDZUKI, M., et al. 1997. Development of atopic dermatitis-like skin lesion with IgE hyperproduction in NC/Nga mice. International Immunology,9, 461-466.
MECKFESSEL, M. H. & BRANDT, S. 2014. The structure, function, and importance of ceramides in skin and their use as therapeutic agents in skin-care products. Journal of the American Academy of Dermatology, 71, 177-184.
MENTON, D. N. & EISEN, A. Z. 1971. Structure and organization of mammalian stratum corneum. Journal of Ultrastructure Research,35, 247-264.
MEYER, W., SCHONNAGEL, B. & FLEISCHER, L. G. 2006. A note on integumental (1–>3)(1–>6)beta-D-glucan permeation, using the porcine ear skin model. J Cosmet Dermatol,5, 130-4.
MIKI, R., ICHITSUKA, Y., YAMADA, T., KIMURA, S., EGAWA, Y., et al. 2015. Development of a membrane impregnated with a poly(dimethylsiloxane)/poly(ethylene glycol) copolymer for a high-throughput screening of the permeability of drugs, cosmetics, and other chemicals across the human skin. European Journal of Pharmaceutical Sciences, 66, 41-49.
MIN, D., LEE, W., BAE, I. H., LEE, T. R., CROCE, P., et al. 2018. Bioprinting of biomimetic skin containing melanocytes. Exp Dermatol, 27, 453-459.
MIZUTANI, Y., MITSUTAKE, S., TSUJI, K., KIHARA, A. & IGARASHI, Y. 2009. Ceramide biosynthesis in keratinocyte and its role in skin function.Biochimie, 91, 784-790.
MOHAPATRA, S., COPPOLA, D., RIKER, A. I. & PLEDGER, W. J. 2007. Roscovitine inhibits differentiation and invasion in a three-dimensional skin reconstruction model of metastatic melanoma. Mol Cancer Res,5, 145-51.
MOJUMDAR, E. H., GOORIS, G. S., GROEN, D., BARLOW, D. J., LAWRENCE, M. J., et al. 2016. Stratum corneum lipid matrix: Location of acyl ceramide and cholesterol in the unit cell of the long periodicity phase.Biochim Biophys Acta, 1858, 1926-34.
MONER, V., FERNÁNDEZ, E., CALPENA, A. C., GARCIA-HERRERA, A., CÓCERA, M., et al. 2018. A lamellar body mimetic system for the treatment of oxazolone-induced atopic dermatitis in hairless mice. Journal of Dermatological Science, 90, 172-179.
MONFORT, A., SORIANO-NAVARRO, M., GARCÍA-VERDUGO, J. M. & IZETA, A. 2013. Production of human tissue-engineered skin trilayer on a plasma-based hypodermis. Journal of Tissue Engineering and Regenerative Medicine, 7, 479-490.
MONIAGA, C. S., EGAWA, G., KAWASAKI, H., HARA-CHIKUMA, M., HONDA, T., et al. 2010. Flaky Tail Mouse Denotes Human Atopic Dermatitis in the Steady State and by Topical Application with Dermatophagoides pteronyssinus Extract. The American Journal of Pathology,176, 2385-2393.
NAGELREITER, C., RAFFEINER, S., GEYERHOFER, C., KLANG, V. & VALENTA, C. 2013. Influence of drug content, type of semi-solid vehicle and rheological properties on the skin penetration of the model drug fludrocortisone acetate. International Journal of Pharmaceutics,448, 305-312.
NAKANO, M. & PATEL, N. K. 1970. Release, Uptake, and Permeation Behavior of Salicylic Acid in Ointment Bases. Journal of Pharmaceutical Sciences, 59, 985-988.
NETZLAFF, F., LEHR, C. M., WERTZ, P. W. & SCHAEFER, U. F. 2005. The human epidermis models EpiSkin, SkinEthic and EpiDerm: an evaluation of morphology and their suitability for testing phototoxicity, irritancy, corrosivity, and substance transport. Eur J Pharm Biopharm,60, 167-78.
NETZLAFF, F., SCHAEFER, U. F., LEHR, C. M., MEIERS, P., STAHL, J., et al. 2006. Comparison of bovine udder skin with human and porcine skin in percutaneous permeation experiments. Altern Lab Anim,34, 499-513.
NG, K. W. & LAU, W. M. 2015. Skin Deep: The Basics of Human Skin Structure and Drug Penetration. In: DRAGICEVIC, N. & MAIBACH, H. I. (eds.) Percutaneous Penetration Enhancers Chemical Methods in Penetration Enhancement: Drug Manipulation Strategies and Vehicle Effects. Berlin Heidelberg: Springer.
OECD 2011. Test No. 156: Guidance notes on dermal absorption.
OECD 2015. Test No. 439: In Vitro Skin Irritation: Reconstructed Human Epidermis Test Method .
OLIVEIRA, G., BEEZER, A. E., HADGRAFT, J. & LANE, M. E. 2010. Alcohol enhanced permeation in model membranes. Part I. Thermodynamic and kinetic analyses of membrane permeation. International Journal of Pharmaceutics, 393, 61-67.
OLIVEIRA, G., BEEZER, A. E., HADGRAFT, J. & LANE, M. E. 2011. Alcohol enhanced permeation in model membranes. Part II. Thermodynamic analysis of membrane partitioning. International Journal of Pharmaceutics,420, 216-222.
OLIVEIRA, G., HADGRAFT, J. & LANE, M. E. 2012. The role of vehicle interactions on permeation of an active through model membranes and human skin. International Journal of Cosmetic Science,34, 536-545.
OTTAVIANI, G., MARTEL, S. & CARRUPT, P.-A. 2006. Parallel Artificial Membrane Permeability Assay:  A New Membrane for the Fast Prediction of Passive Human Skin Permeability. Journal of Medicinal Chemistry,49, 3948-3954.
OVAERE, P., LIPPENS, S., VANDENABEELE, P. & DECLERCQ, W. 2009. The emerging roles of serine protease cascades in the epidermis.Trends Biochem Sci, 34, 453-63.
PALAC, Z., ENGESLAND, A., FLATEN, G. E., SKALKO-BASNET, N., FILIPOVIC-GRCIC, J., et al. 2014. Liposomes for (trans)dermal drug delivery: the skin-PVPA as a novel in vitro stratum corneum model in formulation development. J Liposome Res, 24, 313-22.
PASSERON, T., NAMIKI, T., PASSERON, H. J., LE PAPE, E. & HEARING, V. J. 2009. Forskolin Protects Keratinocytes from UVB-Induced Apoptosis and Increases DNA Repair Independent of its Effects on Melanogenesis.Journal of Investigative Dermatology, 129, 162-166.
PENDARIES, V., MALAISSE, J., PELLERIN, L., LE LAMER, M., NACHAT, R., et al. 2014. Knockdown of filaggrin in a three-dimensional reconstructed human epidermis impairs keratinocyte differentiation.J Invest Dermatol, 134, 2938-2946.
PONEC, M. 1992. In vitro cultured human skin cells as alternatives to animals for skin irritancy screening. Int J Cosmet Sci,14, 245-64.
POPLE, P. V. & SINGH, K. K. 2011. Development and evaluation of colloidal modified nanolipid carrier: Application to topical delivery of tacrolimus. European Journal of Pharmaceutics and Biopharmaceutics, 79, 82-94.
POUILLOT, A., DAYAN, N., POLLA, A. S., POLLA, L. L. & POLLA, B. S. 2008. The stratum corneum: a double paradox. J Cosmet Dermatol,7, 143-8.
PRAUSNITZ, M. R., ELIAS, P. M., FRANZ, T. J., SCHMUTH, M., TSAI, J. C., et al. 2012. Skin barrier and transdermal drug delivery.In: BOLOGNIA, J., JORIZZO, J. L. & SCHAFFER, J. V. (eds.)Dermatology. Philadelphia: Elsevier Saunders.
PRAUSNITZ, M. R., MITRAGOTRI, S. & LANGER, R. 2004. Current status and future potential of transdermal drug delivery. Nat Rev Drug Discov, 3, 115-24.
RADEMACHER, F., SIMANSKI, M., GLÄSER, R. & HARDER, J. 2018. Skin microbiota and human 3D skin models. Experimental Dermatology,27, 489-494.
RANDALL, M. J., JÜNGEL, A., RIMANN, M. & WUERTZ-KOZAK, K. 2018. Advances in the Biofabrication of 3D Skin in vitro: Healthy and Pathological Models. Frontiers in Bioengineering and Biotechnology, 6.
RASHID, A., EDWARD, M. & RICHARDSON, M. D. 1995. Activity of terbinafine on Trichophyton mentagrophytes in a human living skin equivalent model. Medical Mycology, 33, 229-233.
RHEINWALD, J. G. 1989. Methods for clonal growth and serial cultivation of normal human epidermal keratinocytes and mesothelial cells, in Cell Growth and Division, IRL, Oxford.
RHEINWALD, J. G. & GREEN, H. 1975. Serial cultivation of strains of human epidermal keratinocytes: the formation of keratinizing colonies from single cells. Cell, 6, 331-43.
RHEINWALD, J. G. & GREEN, H. 1977. Epidermal growth factor and the multiplication of cultured human epidermal keratinocytes. Nature,265, 421-424.
RIGG, P. C. & BARRY, B. W. 1990. Shed snake skin and hairless mouse skin as model membranes for human skin during permeation studies.J Invest Dermatol, 94, 235-40.
ROUAUD-TINGUELY, P., BOUDIER, D., MARCHAND, L., BARRUCHE, V., BORDES, S., et al. 2015. From the morphological to the transcriptomic characterization of a compromised three-dimensional in vitro model mimicking atopic dermatitis. Br J Dermatol, 173,1006-14.
RUELA, A. L. M., PERISSINATO, A. G., LINO, M. E. D. S., MUDRIK, P. S. & PEREIRA, G. R. 2016. Evaluation of skin absorption of drugs from topical and transdermal formulations. Brazilian Journal of Pharmaceutical Sciences, 52, 527-544.
SAHLE, F. F., WOHLRAB, J. & NEUBERT, R. H. H. 2014. Controlled penetration of ceramides into and across the stratum corneum using various types of microemulsions and formulation associated toxicity studies. European Journal of Pharmaceutics and Biopharmaceutics,86, 244-250.
SALTON, M., KASPRZAK, W. K., VOSS, T., SHAPIRO, B. A., POULIKAKOS, P. I., et al. 2015. Inhibition of vemurafenib-resistant melanoma by interference with pre-mRNA splicing. Nat Commun, 6,7103.
SARKIRI, M., FOX, S. C., FRATILA-APACHITEI, L. E. & ZADPOOR, A. A. 2019. Bioengineered Skin Intended for Skin Disease Modeling.International Journal of Molecular Sciences, 20, 1407.
SATPATHY, A., DATTA, P., WU, Y., AYAN, B., BAYRAM, E., et al.2018. Developments with 3D bioprinting for novel drug discovery.Expert Opinion on Drug Discovery, 13, 1115-1129.
SCHAEFER, U. F., HANSEN, S., SCHNEIDER, M., CONTRERAS, J. L. & LEHR, C. M. 2008. Models for Skin Absorption and Skin Toxicity Testing.